Author Question: Olfactory receptor cells differ from most other neural cells in that they a. die and are replaced ... (Read 57 times)

drink

  • Hero Member
  • *****
  • Posts: 554
Olfactory receptor cells differ from most other neural cells in that they
 
  a. die and are replaced frequently.
 b. replicate by mitosis.
 c. have no dendrites.
 d. use gaseous neurotransmitters exclusively.

Question 2

The toy preferences observed in male and female children support the idea that
 
  a. gender differences in toy selection are primarily the result of socialization, not biology.
 b. gender differences in toy selection are at least partly determined by biology.
 c. there are no gender differences in toy selection until children are the age of 1824 months.
 d. gender differences in toy selection appear early in development, but then decrease as children enter elementary school.



raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library